Research Links

Home
  Fathering
Medical Practice
  Medical
  Research
Teaching
  Resume  
Football
Coaching

Manual
  Personal &
Family
 
 
Asbestos-cancer research
  Tumor Immunology
Clinical trials
  Mesothelioma blood test
Tumor Immunology Group UWA site
  PhD opportunities
WA Institute for Medical Research
  University of Western Australia
Making donations

 The asbestos-cancer Mesothelioma

We have been researching this disease for around 15 years. Here are some details of the disease.

  What is it?
  What causes it?
  How does it happen?
 
What tests are done?
 
What treatment is available?

 What is mesothelioma?|
Mesothelioma is a malignant tumour (a cancer) which arises in the thin tissue which forms a sac around the lung (the “pleura”), abdomen (the “peritoneum”) or heart (the “pericardium”).  The tumour most commonly occurs in the chest (“pleural mesothelioma”).
Pleural mesothelioma is quite distinct from pleural plaques (which are benign, scarred regions of the pleura), is different from asbestosis (which represents scarred non-cancerous scar tissue of the lung itself) and is different from lung cancer (which represents cancer arising in the lung tissue rather than the pleura).

 What causes mesothelioma?
The commonest cause of mesothelioma is asbestos. The most dangerous form of asbestos is blue asbestos (crocidolite) although brown asbestos (amosite) and other forms of asbestos can also cause mesothelioma.  White asbestos (chrysotile) is less likely to do so, although it is often contaminated with mesothelioma-causing types of asbestos.  All forms of asbestos can cause asbestosis and, particularly in smokers, lung cancer.  There are other less common causes of mesothelioma eg. some man-made mineral fibres, radiation etc.

 How common is mesothelioma?
Mesothelioma was a rare disease but since the 1960’s there has been an “epidemic” of this disease.  There are currently 10-20,000 cases per annum throughout the world and the incidence continues to increase each year.  Of great concern is the fact that between 20 and 35% of all patients have never had “significant” exposure to asbestos ie. they represent ordinary individuals from the population who presumable have inhaled asbestos fibres in the past but who cannot recall such exposure.  The Australian federal government (Worksafe) have predicted that mesothelioma will kill more Australians than AIDS.

 How long does it take for mesothelioma to appear?
Whilst asbestos fibres can damage body tissue immediately, it takes many years before a cancer finally breaks out.  Whilst in some cases this interval can be as short as 10 years, generally it is 30 years or more.  During this “incubation period” the asbestos fibres are presumed to be gradually damaging the body’s cells and the cancer only breaks out when sufficient damage has been caused to turn the cell into a cancer cell.  Unfortunately at the present time there are no tests available to detect such changes early, although current research is attempting to develop such a test.

 Who gets mesothelioma?
Currently about 70% of those who develop mesothelioma have had clear exposure to asbestos at some time in their life.  Most have been exposed to asbestos either during its mining, milling and transport or when it has been used in industry (eg. by plumbers, carpenters, ship builders, naval personnel, builders) or as wives of asbestos-exposed workers, people living near asbestos industries, children exposed to asbestos in the environment etc.  Of the 20-35% of patients with mesothelioma who have no significant exposure to asbestos, it is assumed that they have had incidental exposure from the environment as most of these people, like most people in the community, have millions of fibres in each of their lungs.  Many cases are young adults.

Mesothelioma is not contagious.

 How is mesothelioma diagnosed? What tests are done?
There are two main techniques used by doctors to diagnose mesothelioma.  Firstly, by xrays. Chest x-rays may show a lump or an accumulation of fluid outside the lung tissue (mesothelioma tumours can ooze fluid, induce inflammation and possibly block fluid removal).  Often a special xray called a CT scan (“computerised tomography”) will be performed.  This involves the patient laying in a xray tube whilst a special xray machine takes multiple images and generates a computer analysis.   Secondly, and most importantly, doctors will need to obtain some tissue for examination to prove that it is indeed mesothelioma.  This may involve a combination of examination of cells obtained from a fluid collection from a tumour using a needle (“cytology”) and direct examination of a piece of the tumour obtained from a pleural biopsy, from a pleuroscopic biopsy (a doctor looks into the chest cavity through a tube) or, in some cases, from tissue obtained after surgical opening of the chest wall to directly view the pleura.

 A number of complicated laboratory tests are undertaken to confirm that the tumour is indeed mesothelioma rather than some other form of tumour or other type of tissue reaction.  With these modern techniques it is usually possible to be fairly certain that the diagnosis of mesothelioma is correct.

What symptoms does mesothelioma cause?
Many patients have no symptoms at all and their tumour is detected on routine chest xray eg. for an insurance exam or for an operation.  Most patients present with either breathlessness (usually due to fluid accumulation within the chest) or some chest wall pain (assumed to be due to irritation of chest wall nerves by the tumour).

 If the mesothelioma occurs in the peritoneum, swelling of the abdomen often occurs and, in some cases, disturbance of bowel function.

 If mesothelioma occurs in the pericardium (surrounding the heart) then it can exert pressure on the heart and limit its function leading to breathlessness and tissue swelling eg. in the ankles.

 What is the prognosis?
Unfortunately mesothelioma is a very aggressive tumour and the average survival from diagnosis is about 9-12 months.  Of course that only represents the average so many patients will live longer than that eg. 12-18 months whereas others will unfortunately live for less than that eg. 3-5 months.  In general if the tumour is detected early in an individual who is relatively young and healthy then survival is longer than those who present with more advanced tumours.  Whilst occasionally patients live longer than two years, this is very uncommon.

 Usually patients remain fairly well for a large proportion  of the time of the illness. Pain can be controlled by modern medications, as can breathlessness. 

 What treatment is available for mesothelioma?
There are three standard treatment strategies for any cancer, surgery (remove it), radiation therapy (destroy the tumour cells by x-ray beams), or chemotherapy (“poison” the tumour cells with drugs that block the function of dividing cells).  Unfortunately none are effective in mesothelioma.  Surgery is ineffective because the tumour has always spread throughout the pleural cavity at the time of presentation and it is impossible to remove it all.  Even removing most of the tumour does not really improve survival and simply adds another operation to the list of things a patient must undergo.  Surgery can be very useful for controlling fluid accumulation.  Radiation is rarely used because this tumour is very resistant to it, although again they can help alleviate symptoms in some circumstances.

 We have developed a chemotherapy protocol here in Perth based on our research program. This involves using several drugs which we have shown to be capable of killing mesothelioma cells in the test tube. Whilst this type of therapy has a good chance to shrinking mesothelioma tumors and reducing symptoms, it is fair to say that at this stage any benefits are only temporary.

 A number of experimental immunotherapy treatments for mesothelioma have been utilised at the Sir Charles Gairdner Hospital and these are offered to patients on a volunteer basis.  Whilst each of these treatments has had some success (eg. 10-20% of patients get major shrinkage of tumour and a small proportion of these patients have lived for over 5 years), it is important to realise that these treatments are experimental and most patients who undergo them do not respond.  Doctors at the Sir Charles Gairdner Hospital can provide you with specific information regarding these treatment approaches.

 What about alternative treatments for mesothelioma?
Individuals with mesothelioma often ask about potential therapeutic value of different diets, meditation, alternative non-standard therapies etc.  In general it is important that individuals diagnosed with this disease maintain a good well-balanced diet, a regular exercise program and continue with a positive approach to life.  In our opinion these are important and can prolong survival to some extent.  We have not however noticed any additional benefit in those individuals who have utilised any of the above alternative approaches.  We continue to remain open to the possibility that new ways of improving the prognosis for patients with mesothelioma may be found, however we do not believe that there is any additional benefit to the above approaches at this stage.  Of course we respect any patients right to choose whatever management strategy they wish to choose and we will always continue to provide the best of care in the traditional medical setting even if alternative approaches are tried by patients.

 What is the Mesothelioma Research Unit?
This unit has been established in the University Department of Medicine and Department of Respiratory Medicine at Sir Charles Gairdner Hospital.

 Because of the widespread exposure of Western Australians to blue asbestos, mesothelioma is unfortunately common in this State.  Doctors in many disciplines have substantial experience in studying this disease.  Over the past 15 years or so we have applied the latest technological developments in medical research to this disease and have established a program of research aimed at trying to understand exactly how mesothelioma cells grow, why they are not destroyed by the body’s immune defences and how we can destroy the tumour effectively.  This involves a mixture of laboratory research and clinical treatment trials in patients with the disease.  The group has published hundreds of papers on mesothelioma in international journals and has written numerous books as well as book chapters on their work, as well as presenting their work at many international conferences and overseas institutions.  The unit has been internationally recognised as a world leader in this field.

 “The mesothelioma research done in this unit in Perth leads the world. We have admired their work for years”.
Dr LK, Philadelphia, USA.

 What can I do to help mesothelioma research?
The sophisticated laboratory research and the clinical trials in patients with mesothelioma are very expensive to undertake.  Substantial research funds are hard to acquire in Australia so continued support is always a priority.

 If you wish to help you could donate to the research directly and/or arrange a bequest to the research.   

For further information

On the Mesothelioma Research Unit
(
Web address is: http://www.meddent.uwa.edu.au/medicine/groups/
(click on ‘Tumor Immunology Group’) 

On diagnosis and treatment:
Contact your own local GP and/or your chest specialist.

 On cancer services available in Western Australia:
Contact the Cancer Foundation of Western Australia at
334 Rokeby Road, Subiaco  Western Australia  6008
Phone: 13 1120

 On asbestos diseases support services available in Western Australia:
Contact the Asbestos Diseases Society at
483 Charles Street, North Perth  Western Australia  6006
Phone: 9444 6699

 On the work of the Mesothelioma Research Unit:
Contact the Secretary, Mesothelioma Research Unit
University Department of Medicine
QEII Medical Centre,
Perth Western Australia 6009\
Phone: 9346 2005

 Donating to the Mesothelioma Research Unit

If you wish to either donate money or make a bequest to support the work of the Mesothelioma Research Unit, please

Send a cheque or money order to:
Secretary, Mesothelioma Research Unit
University Department of Medicine
QEII Medical Centre, Nedlands Western Australia 6009
Telephone: 9346 2005/9346 2098. Fax: 9346 2816

Cheques should me made out to “Mesothelioma Research Unit - SCGH Account 2201

Donations over $2 are tax deductible and a receipt will be forwarded to you from the hospital accountant.

 Arranging a bequest
A bequest represents a statement in your will that you wish to make a donation of a specific amount to the Mesothelioma Research Unit. 

1. If you have not already made a will this can be done either through a lawyer or you can make your own will (will forms are available from newsagents or stationers), although you will need two independent adult witnesses who are not beneficiaries of the will to sign the will at the same time, with the same pen in the same room. 

2. You should list the beneficiary as “Mesothelioma Research Unit - SCGH Account 2201”, University Department of Medicine, QEII Medical Centre, Nedlands  6009.

3. You should inform the executor of your will of your request. 

If you would like to receive further information or assistance regarding this please contact the secretary:

Secretary, Mesothelioma Research Unit
University Department of Medicine, QEII Medical Centre
Nedlands, Western Australia 6009

Tel 08 9346 2005 or 9346 2098

 
© 2004  Bruce Robinson.                        Disclaimer